Sartorius Stedim Cellca, a Laupheim, Germany-based company specializing in mammalian cell-line and upstream process development, is building a new EUR 30-million ($35-million) Cell Culture Technology Center at Science Park III situated at the northwestern scientific hub of Ulm, Germany.

Sartorius Stedim Cellca has been working in a rented building in Laupheim. The new laboratory and office complex will approximately double the company’s space and is scheduled to be completed by the end of 2019. In addition, relocation to this zone will provide closer proximity to universities and research institutes that are based in Ulm’s science park. Sartorius Stedim Cellca purchased the property of more than 6,000 square-meters at Science Park III in November 2016, and it can expand its Cell Culture Technology Center by a further 5,000 square-meters as needed.

Sartorius Stedim Cellca develops cell lines and protein production processes, licenses technologies for the production of proteins, and offers cell-culture media. Since 2015, the company has been a part of the biopharma equipment supplier Sartorius Stedim Biotech, located in Aubagne, France, and currently employs around 90 people. Over the medium term, the company plans to extend its workforce to more than 120 people.

Source: Sartorius Stedim